By immunostaining, CCL21 expression was also higher in neoplastic samples than in normal tissues, and increased with glioma grades, with highest expression in WHO grade IV GBMs (Fig. 1c, Supplementary Fig. 1a, b, Table 2). This evidence concerns the gene CCL21 and central nervous system cancer.